Recurrent miscarriage is defined as two or more consecutive pregnancy losses. It affects roughly 1-2% of couples trying to conceive. The most common causes of chromosomal abnormalities (errors in the embryo’s genetic material), uterine structural issues, blood clotting disorders, and hormonal imbalances are all investigatable, and most are treatable. With proper testing and care, the majority of couples go on to have a successful pregnancy.
If you’ve experienced two or more miscarriages, please know this first: you have done nothing wrong, the losses are not your fault, and a clear medical pathway exists to find answers. This guide is written to help you understand what comes next. It is not a substitute for compassionate, individual care from a fertility specialist.
Recurrent miscarriage, also called recurrent pregnancy loss or RPL, is the medical term for two or more consecutive pregnancy losses before 20 weeks of gestation (the time from the first day of your last period). It is a condition in its own right, distinct from a single miscarriage, and is investigated differently. Most international guidelines (including those from the Royal College of Obstetricians and Gynaecologists, or RCOG, in the UK and the European Society of Human Reproduction and Embryology, or ESHRE) now recommend starting investigations after the second loss rather than waiting for a third because earlier testing means earlier answers.
A single miscarriage is, statistically, common; around 15% of all recognised pregnancies end this way, and the cause is most often a one-time genetic error in the embryo that does not predict future losses. Two consecutive losses change the picture. The probability that the same random error has occurred twice in a row drops sharply, which is why specialist guidelines recommend evaluation at this point. This is not overtesting or being alarmist; it is the standard of care across modern fertility medicine. Investigation looks for treatable conditions in five categories: genetic factors (in either parent or the embryo), uterine structural issues, blood clotting disorders, hormonal imbalances, and immune or inflammatory conditions. In around half of all cases, the workup identifies a cause that can be specifically treated. In the other half, a structured pregnancy management plan still significantly improves outcomes.
A thorough evaluation looks at both partners and the pregnancies themselves. The standard panel after two losses typically covers parental karyotyping (a blood test in both partners that maps the structure of their chromosomes the bundles of DNA inside each cell), products-of-conception testing (genetic analysis of the miscarriage tissue, where available), a detailed pelvic ultrasound and either a hysterosalpingogram (HSG, an X-ray that uses dye to outline the uterine cavity and fallopian tubes) or a hysteroscopy (a small camera passed into the uterus) to assess the uterine shape, antiphospholipid antibody testing (a blood test for an immune condition that increases clotting risk), thyroid function and thyroid autoantibodies, fasting glucose and HbA1c (a measure of average blood sugar over three months), prolactin (a hormone affecting ovulation), and a complete pelvic assessment for conditions like endometriosis or adenomyosis (tissue similar to the uterine lining growing in the uterine muscle wall).
Treatment for recurrent miscarriage in India is highly cause-specific; generic treatment is rarely useful. If the workup finds antiphospholipid syndrome (APS), management combines blood-thinning medication and aspirin under specialist supervision and substantially improves live birth rates. If a uterine septum (a wall of tissue dividing the uterine cavity) is found, a small day-care surgery called hysteroscopic septum resection can correct it. If thyroid dysfunction or poorly controlled blood sugar is identified, optimisation of those conditions before the next conception attempt makes a meaningful difference. If a parental chromosome rearrangement (called a balanced translocation) is found, In-vitro Fertilization (IVF) with preimplantation genetic testing for structural rearrangements (PGT-SR) allows only chromosomally balanced embryos to be transferred.
The single largest cause of first-trimester recurrent miscarriage, accounting for roughly 50% of cases, is chromosomal errors in the embryo itself, most often related to egg quality. This risk rises sharply with maternal age, particularly above 35. For couples where embryo aneuploidy (an abnormal chromosome count in the embryo) is suspected or confirmed, IVF with preimplantation genetic testing for aneuploidy (PGT-A) is the most evidence-based intervention. PGT-A tests a few cells from each embryo to check whether its chromosome count is normal before transfer. Studies show this can reduce the per-transfer miscarriage rate substantially. PGT-A does not eliminate miscarriage risk, but for the right indication, maternal age over 35, multiple losses, or a history of confirmed aneuploid pregnancies, it is among the most powerful tools available. Whether it’s right for you depends on your specific findings and should be discussed with a fertility specialist.
Most cases of recurrent miscarriage fall into one of the categories below. Often, more than one factor is at play.
• Embryo chromosomal abnormalities: Errors in the embryo’s chromosome count or structure are the leading cause of first-trimester losses, accounting for roughly half of miscarriages and rising with maternal age above 35.
• Parental chromosomal rearrangements: In about 3-5% of recurrent miscarriage cases, one parent carries a balanced translocation, a rearrangement of chromosome material that is harmless to them but produces unbalanced embryos that miscarry.
• Uterine structural issues: A uterine septum (dividing wall), large fibroids inside the uterine cavity, intrauterine adhesions (scar tissue, also called Asherman syndrome), or a T-shaped uterus can all interfere with implantation or early pregnancy.
• Antiphospholipid syndrome (APS): An autoimmune condition where the body produces antibodies that increase blood clotting, restricting blood flow to the developing pregnancy. APS is found in around 15% of recurrent miscarriage cases and is treatable.
• Endocrine and metabolic factors: Untreated thyroid dysfunction, poorly controlled diabetes, raised prolactin, polycystic ovary syndrome (PCOS), and obesity are all linked to higher miscarriage risk, and all are modifiable.
• Inherited blood clotting disorders (thrombophilias): Conditions such as Factor V Leiden or protein S deficiency can contribute, particularly to second-trimester losses, though their role in first-trimester recurrent miscarriage is more limited.
• Subclinical chronic endometritis: Low-grade inflammation in the uterine lining, often without obvious symptoms, is increasingly recognised as a treatable cause of unexplained recurrent loss.
• Lifestyle and environmental factors: Smoking, heavy alcohol use, very high or very low body weight, untreated chronic stress, and exposure to certain environmental toxins all raise miscarriage risk and are addressable.
• Don’t wait for a third loss to start investigating; modern guidelines recommend testing after the second.
• Ask for parental karyotyping (chromosome analysis) for both you and your partner.
• Request products-of-conception testing if a future loss occurs. This is the single most informative test, when feasible.
• Confirm a complete pelvic assessment was done: ultrasound plus either an HSG or hysteroscopy to map the uterine cavity in detail.
• Check that antiphospholipid antibody testing was repeated 12 weeks apart (a single positive result is not diagnostic).
• Verify thyroid function (TSH, free T4, and anti-TPO antibodies), fasting glucose with HbA1c, and prolactin were all included.
• If you’re over 35 or have had three or more losses, ask whether IVF with PGT-A should be discussed earlier in your treatment plan.
• Optimise modifiable health factors before the next attempt: stop smoking, limit alcohol, address weight if outside healthy range, manage thyroid and blood sugar, and prioritise sleep.
• Consider mental health support, grief after pregnancy loss is real, repeated loss compounds it, and structured counselling significantly reduces anxiety in the next pregnancy.
• Lean on support networks: a partner, trusted friends or family, or a peer support group for pregnancy loss. Isolation worsens outcomes; connection helps.
• Be patient with the process. A complete workup takes 6-8 weeks; treatment planning depends on those results. Skipping steps usually costs more time later.
• If your current care feels rushed, dismissive, or focused on “just try again,” seek a second opinion at a fertility specialist clinic with experience in recurrent loss.
Cloudnine Fertility Hospital offers a structured recurrent pregnancy loss programme combining the full investigative panel, individualised treatment based on the cause identified, and preconception optimisation before the next attempt. Most couples we see have already had two or three losses elsewhere; a full workup typically uncovers a treatable factor that hasn’t yet been investigated.
After even one loss, your obstetrician can offer support. After two or more losses, evaluation moves into specialist territory. The thresholds below should trigger a referral to a fertility specialist with experience in recurrent miscarriage.
If you’ve had two or more losses, book a structured consultation with our experts. A complete workup, a clear explanation of findings, and a preconception plan tailored to your specific cause are the foundation of a successful next pregnancy.
Many couples are surprised to learn how good the prognosis remains, even after multiple losses. The figures below summarise typical live-birth outcomes for the next pregnancy, based on age and number of prior losses, when proper investigation and management are in place.
Note: These ranges represent live birth rates in the next pregnancy under typical Indian clinical conditions. Individual outcomes vary substantially based on the specific cause identified, response to treatment, and overall health. Cumulative success across multiple attempts is meaningfully higher than per-attempt rates.